文献速递系统性红斑狼疮其他结缔组织病

精神病患者抗核抗体阳性者神经精神性狼疮患病率低

Prevalence of Neuropsychiatric Lupus in Psychosis Patients Who Have Tested Positive for Antinuclear Antibodies.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-01-25

该研究回顾性分析了两个城市三级转诊中心精神科收治的精神病患者,其中911例检测了抗核抗体(ANA),135例(15%)ANA滴度≥1:160阳性。随访期间仅2例符合神经精神性系统性红斑狼疮(NPSLE),ANA阳性者中NPSLE患病率为1.5%,全部检测者中为0.2%。作者认为精神病患者常规检测ANA的依据不足。

要点

  • 精神病患者中ANA阳性率15%,但NPSLE患病率仅1.5%。
  • 全部接受ANA检测的精神病患者中NPSLE患病率低至0.2%。
  • 低临床显著阳性率不支持精神病患者常规检测ANA。

核心结论

  • 精神病且ANA阳性患者中NPSLE患病率为1.5%,属于低患病率。
  • 临床显著阳性结果比例低,不支持对精神病患者常规检测ANA。

研究设计与样本

  • 回顾性研究,纳入两个城市三级转诊中心精神科收治的精神病患者。
  • 共10205例次精神科入院,代表4766例个体患者。
  • 911例患者检测了ANA,135例(15%)ANA滴度≥1:160阳性。
  • 平均随访时间47±26个月。

主要发现

  • 出院时4例符合2019年ACR/EULAR的SLE分类标准,其中2例符合NPSLE标准。
  • ANA阳性患者中NPSLE患病率为1.5%(2/135)。
  • 全部接受ANA检测的患者中NPSLE患病率为0.2%(2/911)。

关键数值与推荐

  • SLE诊断依据2019年ACR/EULAR分类标准。
  • NPSLE归因依据经验证的标准。
  • ANA阳性定义为滴度≥1:160。

临床怎么用

  • 对精神病患者不应常规检测ANA,因临床显著阳性率低。
  • ANA阳性精神病患者中NPSLE患病率低,需结合其他临床表现评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Psychosis is a rare manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE). Current guidelines do not make a recommendation regarding the use of antinuclear antibody (ANA) testing in the assessment of patients with psychosis. The present study was undertaken to determine the prevalence of NPSLE in patients with psychosis who were positive for ANAs. METHODS: A retrospective review of patients who were admitted to the mental health service of 2 metropolitan tertiary referral centers with a diagnosis of psychosis and had been tested for ANAs was conducted. A diagnosis of SLE was made when the 2019 American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) classification criteria were fulfilled. Attribution of psychosis-related events to NPSLE were made according to validated criteria. RESULTS: There were 10,205 mental health admissions with diagnoses of psychosis representing 4,766 individual patients, 911 patients (19%) were tested for ANAs, 135 (15%) of those tests returned a positive result with a titer of ≥1:160. The mean ± SD follow-up time was 47 ± 26 months. At discharge, there were 4 patients who met 2019 ACR/EULAR criteria for SLE, 2 of whom met criteria for NPSLE (2 patients had other manifestations of SLE), yielding an NPSLE prevalence of 1.5% (2 of 135) among patients who were positive for ANAs, and 0.2% (2 of 911) among all patients who underwent testing for ANAs. CONCLUSION: The prevalence of NPSLE in patients with psychosis who were positive for ANAs was low, at 1.5%. The low rate of clinically significant positive results would argue against routine testing for ANAs in patients with psychosis.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Spies MC, Gutjahr-Holland JA, Bertouch JV, et al. Prevalence of Neuropsychiatric Lupus in Psychosis Patients Who Have Tested Positive for Antinuclear Antibodies. Arthritis Care Res (Hoboken). 2022. PMID: 33002303. doi:10.1002/acr.24472

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。